RET and medullary thyroid gland carcinoma: In conclusion, this study provides the first comprehensive genetic characterization of MTC in a Romanian cohort, revealing a higher-than-expected hereditary fraction (35.9%) and highlighting the critical importance of germline RET screening in all MTC patients, irrespective of their clinical presentation or family history.